Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: A National Cancer Database analysis

Gynecologic Oncology

Volumn 139, Issue 1, 2015, Pages 84-89

  Rauh Hain, J Alejandro ^a   Starbuck, Kristen D ^a   Meyer, Larissa A ^b   Clemmer, Joel ^a   Schorge, John O ^a   Lu, Karen H ^b   Del Carmen, Marcela G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Chemotherapy; Endometrial cancer; Uterine carcinosarcoma

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOSARCOMA; FEMALE; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; UTERUS CARCINOMA; UTERUS CARCINOSARCOMA; AGE; EPIDEMIOLOGY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME; UNITED STATES; UTERINE NEOPLASMS; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOSARCOMA; CHEMORADIOTHERAPY, ADJUVANT; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME; UNITED STATES; UTERINE NEOPLASMS;

EID: 84943358038     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2015.08.014     Document Type: Article

References (34)

1. R. Siegel, J. Ma, Z. Zou, and A. Jemal Cancer statistics, 2014 CA Cancer J. Clin. 64 1 2014 9 29
2. C.L. Creutzberg, W.L. van Putten, P.C. Koper, M.L. Lybeert, and et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma Lancet 355 2000 1404 1411
3. J.A. Rauh-Hain, A. Buskwofie, J. Clemmer, and R.M. Clark Racial disparities and Trends in Treatment of High-Grade Endometrial Cancer in the Medicare Population Obstet. Gynecol. 125 4 2015 843 851
4. A. Gadducci, E. Sartori, F. Landoni, P. Zola, T. Maggino, S. Cosio, G. Tisi, A. Lissoni, A.M. Ferrero, and R. Cristofani The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases Eur. J. Gynaecol. Oncol. 23 4 2002 295 299
5. A. Wolfson, M. Brady, T. Rocereto, R. Mannel, Y. Lee, R. Futoran, D. Cohn, and O. Ioffe A Gynecologic Oncology Group Randomized Phase III Trial of Whole Abdominal Irradiation (WAI) as Post-Surgical Therapy in Stage I-IV Carcinosarcoma (CS) of the Uterus Gynecol. Oncol. 107 2 2007 177 185
6. J.A. Rauh-Hain, M. Shoni, J.O. Schorge, A. Goodman, N.S. Horowitz, and M.G. del Carmen Prognostic determinants in patients with uterine and ovarian carcinosarcoma J. Reprod. Med. 58 7-8 2013 297 304
7. P. Inthasorn, J. Carter, S. Valmadre, P. Beale, and et al. Analysis of clinicopathologic factors in malignant mixed Mullerian tumors of the uterine corpus Int. J. Gynecol. Cancer 12 2002 348 353
8. F. Major, J. Blessing, S. Silverberg, P. Morrow, W. Creasman, J. Currie, E. Yordan, and M. Brady Prognostic Factors in Early-stage Uterine Sarcoma Cancer 71 4 1993 1702 1709
9. S.E. Brooks, M. Shan, T. Cote, and C.R. Baquet Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999 Gynecol. Oncol. 93 1 2004 204 208
10. E. D'Angelo, and J. Prat Uterine sarcomas: a review Gynecol. Oncol. 116 1 2010 131 139
11. M.V. Raval, K.Y. Bilimoria, A.K. Stewart, D.J. Bentrem, and C.Y. Ko Using the NCDB for cancer care improvement: an introduction to available quality assessment tools J. Surg. Oncol. 99 8 2009 488 490
12. J.R. Howe, L.H. Karnell, H.R. Menck, and C. Scott-Conner Adenocarcinoma of the small bowel, Review of the National Cancer Data Base, 1985-1995 Cancer 86 12 1999 2693 2706
13. M. Koshy, S.A. Fedewa, R. Malik, and et al. Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA (N2) non-small-cell lung cancer J. Thorac. Oncol. 8 2013 915 922
14. A.M. Ganapathi, P.J. Speicher, B.R. Englum, A.W. Castleberry, J. Migaly, D.S. Hsu, and C.R. Mantyh Adjuvant chemotherapy for t1 node-positive colon cancers provides significant survival benefit Dis. Colon Rectum 57 12 2014 (1341-18)
15. N.M. Rueth, H.Y. Lin, I. Bedrosian, S.F. Shaitelman, N.T. Ueno, Y. Shen, and G. Babiera Underuse of trimodality treatment affects survival for patients with inflammatory breast cancer: an analysis of treatment and survival trends from the National Cancer Database J. Clin. Oncol. 32 19 2014 2018 2024
16. B. Rungruang, and A.B. Olawaiye Comprehensive surgical staging for endometrial cancer Rev. Obstet. Gynecol. 5 1 2012 28 34
17. S. Raigani, J.M. Hardacre, J. Kim, and J.B. Ammori Trends in the surgical treatment of gastric adenocarcinoma Ann. Surg. Oncol. 21 2 2014 569 574
18. C.N. Klabunde, A.L. Potosky, J.M. Legler, and et al. Development of a comorbidity index using physician claims data J. Clin. Epidemiol. 53 12 2000 1258 1267
19. M.E. Charlson, P. Pompei, K.L. Ales, and et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J. Chronic Dis. 40 5 1987 373 383
20. J.A. Rauh-Hain, J. Clemmer, R.M. Clark, L.S. Bradford, W.B. Growdon, A. Goodman, and et al. Management and outcomes for elderly women with vulvar cancer over time BJOG 121 6 2014 719 727
21. V. Makker, N.R. Abu-Rustum, K.M. Alektiar, C.A. Aghajanian, Q. Zhou, A. Iasonos, and M.L. Hensley A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma Gynecol. Oncol. 111 2 2008 249 254
22. S.N. Nielsen, K.C. Podratz, B.W. Scheithauer, and P.C. O'Brien Clinicopathologic analysis of uterine malignant mixed Müllerian tumors Gynecol. Oncol. 34 3 1989 372 378
23. E. Sartori, L. Bazzurini, A. Gadducci, F. Landoni, A. Lissoni, T. Maggino, P. Zola, and B. La Face Carcinosarcoma of the Uterus: A Clinicopathological Multicenter CTF Gynecol. Oncol. 67 1 1997 70 75
24. B.K. Erickson, D.W. Doo, B. Zhang, W.K. Huh, and C.A. Leath III Black race independently predicts worse survival in uterine carcinosarcoma Gynecol. Oncol. 133 2 2014 238 241
25. G. Garg, C. Yee, K. Schwartz, D.G. Mutch, R.T. Morris, and M.A. Rowell Patterns of care, predictors, and outcomes of chemotherapy in elderly women with early-stage uterine carcinosarcoma: a population-based analysis Gynecol. Oncol. 133 2 2014 242 249
26. H.D. Homesley, V. Filiaci, M. Markman, P. Bitterman, L. Eaton, L.C. Kilgore, and B.J. Monk Ueland FR; Gynecologic Oncology Group. Phase III trial of ifosfamide with or without paclitaxel in advanced uterine cacinosarcoma: a Gynecologic Oncology Group Study J. Clin. Oncol. 25 5 2007 526 531
27. G. Sutton, J. Kauderer, L.F. Carson, S.S. Lentz, and C.W. Whitney Gallion H; Gynecologic Oncology Group. Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study Gynecol. Oncol. 96 3 2005 630 634
28. M.A. Powell, V.L. Filiaci, P.G. Rose, R.S. Mannel, P. Hanjani, K. Degeest, B.E. Miller, N. Susumu, and F.R. Ueland Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study J. Clin. Oncol. 28 16 2010 2727 2731
29. G. Sutton, V.L. Brunetto, L. Kilgore, J.T. Soper, R. McGehee, G. Olt, S.S. Lentz, J. Sorosky, and J.G. Hsiu A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study Gynecol. Oncol. 79 2 2000 147 153
30. N.S. Reed, C. Mangioni, H. Malmstrom, G. Scarfone, A. Poveda, S. Pecorelli, S. Tateo, M. Franchi, and et al. European Organisation for research and Treatment of Cancer Gynaecological Cancer Group Eur. J. Cancer 44 6 2008 808 816
31. R.A. Lacour, E. Euscher, E.N. Atkinson, C.C. Sun, P.T. Ramirez, R.L. Coleman, J. Brown, and et al. A phase II trial of paclitaxel and carboplatin in women with advanced or recurrent uterine carcinosarcoma Int. J. Gynecol. Cancer 21 3 2011 517 522
32. A. Otsuki, Y. Watanabe, H. Nomura, M. Futagami, Y. Yokoyama, K. Shibata, and et al. Paclitaxel and carboplatin in patients with completely or optimally resected carcinosarcoma of the uterus: a phase II trial by the Japanese Uterine Sarcoma Group and the Tohoku Gynecologic Cancer Unit Int. J. Gynecol. Cancer 25 1 2015 92 97
33. S.M. Kehoe, and D.S. Miller The role of lymphadenectomy in endometrial cancer Clin. Obstet. Gynecol. 54 2 2011 235 244
34. J.Y. Park, D.Y. Kim, J.H. Kim, Y.M. Kim, Y.T. Kim, and J.H. Nam The role of pelvic and/or para-aortic lymphadenectomy in surgical management of apparently early carcinosarcoma of uterus Ann. Surg. Oncol. 17 3 2010 861 868